000 01485 a2200421 4500
005 20250515095237.0
264 0 _c20081016
008 200810s 0 0 eng d
022 _a0342-4642
024 7 _a10.1007/s00134-007-0935-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aEhrmann, Stephan
245 0 0 _aPharmacokinetics of high-dose nebulized amikacin in mechanically ventilated healthy subjects.
_h[electronic resource]
260 _bIntensive care medicine
_cApr 2008
300 _a755-62 p.
_bdigital
500 _aPublication Type: Comparative Study; Controlled Clinical Trial; Journal Article
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdult
650 0 4 _aAerosols
650 0 4 _aAmikacin
_xadministration & dosage
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aArea Under Curve
650 0 4 _aBiological Availability
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug-Related Side Effects and Adverse Reactions
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aInfusions, Intravenous
650 0 4 _aMale
700 1 _aMercier, Emmanuelle
700 1 _aVecellio, Laurent
700 1 _aTernant, David
700 1 _aPaintaud, Gilles
700 1 _aDequin, Pierre-François
773 0 _tIntensive care medicine
_gvol. 34
_gno. 4
_gp. 755-62
856 4 0 _uhttps://doi.org/10.1007/s00134-007-0935-1
_zAvailable from publisher's website
999 _c17561361
_d17561361